title: Efficacy and Tolerability of Peginterferon α -2a and Peginterferon α -2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials.
abstract: Background. The efficacy and tolerability of peginterferon α -2a and peginterferon α -2b in chronic hepatitis C (CHC) patients remain controversial. Methods. PubMed, Ovid, and Cochrane libraries were electronically searched until August 30, 2012. Studies that met the inclusion criteria were systematically evaluated by two reviewers independently. Results. The overall sustained virologic response (SVR) rate of the peginterferon α -2a group was significantly higher than that of the peginterferon α -2b group (46.7% versus 42.4%, P value = 0.01). The same tendency was observed for naïve, genotype 1/4, and genotype 2/3 patients. The early virologic response (EVR) and end-of-treatment response (ETR) rates were significantly higher in the peginterferon α -2a group than in the peginterferon α -2b group (56.1% versus 49.8%, P < 0.0001; 67.9% versus 56.6%, P < 0.00001, resp.). Peginterferon α -2a had a significantly lower discontinuation rate than peginterferon α -2b (27.9% versus 33.9%, P < 0.0001) in naïve patients. In both naïve CHC and hepatitis C virus genotype 1 patients, peginterferon α -2a had a higher relapse rate than peginterferon α -2b. Conclusions. Peginterferon α -2a has superior efficacy with higher EVR, ETR, and SVR than peginterferon α -2b for CHC patients, both plus ribavirin. Peginterferon α -2a might obtain a similar or even lower discontinuation rate than peginterferon α -2b. However, peginterferon α -2a had a higher relapse rate than peginterferon α -2b.
authors: Shanghai Public Health Clinical Center Affiliated to Fudan University, Department of Traditional Chinese Medicine, No. 2901 Caolang Road, Jinshan District, Shanghai 201508, China.
authors: Zongguo
authors: Z
authors: Yang
authors: Liping
authors: L
authors: Zhuang
authors: Lei
authors: L
authors: Yang
authors: Xiaorong
authors: X
authors: Chen
references: J Viral Hepat. 2007 Oct;14(10):721-9
references: 17875007
references: Semin Liver Dis. 2003;23 Suppl 1:23-8
references: 12934165
references: Hepatology. 2010 Apr;51(4):1176-84
references: 20187106
references: Intervirology. 2010;53(3):146-53
references: 20068348
references: Hepatol Int. 2012 Apr;6(2):409-35
references: 26201405
references: Turk J Gastroenterol. 2006 Jun;17(2):94-8
references: 16830289
references: Hepatology. 2009 Apr;49(4):1335-74
references: 19330875
references: Ann Intern Med. 2004 Mar 2;140(5):346-55
references: 14996676
references: Gastroenterology. 2010 Jan;138(1):116-22
references: 19852964
references: Hepatology. 2009 Jan;49(1):22-31
references: 19085908
references: Liver Int. 2009 Jan;29 Suppl 1:89-99
references: 19207971
references: Dig Dis Sci. 2011 Aug;56(8):2221-6
references: 21643737
references: J Med Virol. 2010 Oct;82(10):1640-6
references: 20827759
references: Aliment Pharmacol Ther. 2004 Oct 15;20(8):825-30
references: 15479353
references: Aliment Pharmacol Ther. 2007 Aug 1;26(3):369-76
references: 17635371
references: Pol Arch Med Wewn. 2011 Dec;121(12):434-9
references: 22157768
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: J Hepatol. 2008 Oct;49(4):634-51
references: 18715665
references: Gastroenterology. 2012 May;142(6):1340-1350.e1
references: 22537441
references: J Antimicrob Chemother. 2011 May;66(5):1127-39
references: 21393126
references: J Viral Hepat. 2012 Jan;19 Suppl 1:37-41
references: 22233412
references: Clin Ther. 2010 Aug;32(9):1565-77
references: 20974315
references: J Hepatol. 2006 Aug;45(2):204-13
references: 16780997
references: Drugs. 2008;68(6):791-801
references: 18416586
references: N Engl J Med. 2009 Aug 6;361(6):580-93
references: 19625712
references: Antivir Ther. 2004 Aug;9(4):491-7
references: 15456079
references: Drugs. 2010;70(2):147-65
references: 20108989
references: Hepat Mon. 2010 Spring;10(2):121-31
references: 22312385
references: J Interferon Cytokine Res. 2008 Oct;28(10):623-9
references: 18778199
references: N Engl J Med. 2002 Sep 26;347(13):975-82
references: 12324553
references: J Viral Hepat. 2009 Aug;16(8):586-94
references: 19552664
references: J Hepatol. 2011 Aug;55(2):245-64
references: 21371579
references: Gastroenterology. 2010 Jan;138(1):108-15
references: 19766645